Replimune Group Inc (REPL) Transcripts

Replimune Group Inc at JPMorgan Healthcare Conference Transcript
Jan 14, 2026
Q4 2025 Replimune Group Inc Earnings Call Transcript
May 22, 2025

$8.76 (+3.55%)

Earnings
Replimune Group Inc at JPMorgan Healthcare Conference Transcript
Jan 08, 2024
Replimune Group Inc RP1 Program Update Call Transcript
Dec 05, 2023
Replimune Group Inc at JPMorgan Healthcare Conference Transcript
Jan 09, 2023
Replimune Group Inc to Host Virtual Investor Event Transcript
Dec 07, 2022
Replimune Group Inc To Host Investor Day Transcript
Mar 30, 2022
Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 10, 2022
Replimune Group Inc Annual Shareholders Meeting Transcript
Sep 08, 2021
Replimune Group Inc Virtual Investor Event Corporate Call Transcript
Jun 03, 2021
Replimune Group Inc at Barclays Global Healthcare Conference (Virtual) Transcript
Mar 11, 2021
Replimune Group Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 12, 2021
Replimune Group Inc to Provide Phase 1/2 Clinical Data Update on Patients with Melanoma and Non-Melanoma Skin Cancers - Conference Call Transcript
Jun 03, 2020
Replimune Group Inc at JPMorgan Healthcare Conference Transcript
Jan 15, 2020

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.